PROSTATE ADENOCARCINOMA
Clinical trials for PROSTATE ADENOCARCINOMA explained in plain language.
Never miss a new study
Get alerted when new PROSTATE ADENOCARCINOMA trials appear
Sign up with your email to follow new studies for PROSTATE ADENOCARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New MRI-Guided radiation aims to cut prostate cancer treatment time and side effects
Disease control TerminatedThis study tested a new way to give radiation therapy for high-risk prostate cancer. Using MRI guidance, doctors delivered higher doses of radiation in fewer sessions, targeting the prostate and nearby lymph nodes while sparing healthy tissue. The goal was to shorten treatment ti…
Matched conditions: PROSTATE ADENOCARCINOMA
Phase: PHASE2 • Sponsor: Thomas Jefferson University • Aim: Disease control
Last updated May 15, 2026 11:56 UTC
-
Prostate cancer study seeks to lower drug doses without losing effect
Disease control TerminatedThis study aimed to find the lowest effective dose of the prostate cancer drug abiraterone for men starting treatment. Researchers planned to enroll 50 men and test different doses over 12 weeks, measuring hormone levels and PSA. The study was terminated early, so results are lim…
Matched conditions: PROSTATE ADENOCARCINOMA
Phase: PHASE1 • Sponsor: University of Chicago • Aim: Disease control
Last updated Apr 26, 2026 19:35 UTC
-
Supplement cocktail fails to soothe radiation side effects in prostate cancer patients
Symptom relief TerminatedThis study aimed to see if a supplement called Q-Urol (containing quercetin, bromelain, rye flower pollen, and papain) could reduce prostatitis symptoms in men with prostate cancer who had brachytherapy radiation. Only 10 men were enrolled before the study was stopped early. The …
Matched conditions: PROSTATE ADENOCARCINOMA
Phase: PHASE2 • Sponsor: University of Utah • Aim: Symptom relief
Last updated May 14, 2026 12:02 UTC
-
Urine DNA test for prostate cancer explored in small study
Knowledge-focused TerminatedThis study aimed to see if DNA markers found in urine could help detect prostate cancer. Researchers planned to collect urine and prostate fluid samples from 24 men with or at risk for prostate cancer. The study was terminated early, so results are limited.
Matched conditions: PROSTATE ADENOCARCINOMA
Sponsor: Mayo Clinic • Aim: Knowledge-focused
Last updated May 16, 2026 23:48 UTC